Home > Insider Trading > Filing (0001209191-11-048897)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1178711	Transcept Pharmaceuticals Inc	TSPT	Pharmaceutical Preparations (2834)	330960223

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1381980	S Nina Kjellson	2710 Sand Hill Rd Suite 200 Menlo Park CA 94025		No	No	Yes	No
1398927	Interwest Management Partners Ix, Llc	2710 Sand Hill Rd Suite 200 Menlo Park CA 94025		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common	Acquisiton	2011-09-21	217,228	$7.24	1,983,884	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The purchase price reported in column 4 of Table 1 represents the average purchase price of the shares purchased ranging from $6.96 to $7.50 per share. Upon request of the commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price.
The shares are owned by InterWest Partners IX, LP ("IW9"). InterWest Management Partners IX, LLC ("IMP9") is the general partner of IW9. Harvey B. Cash, Philip T. Gianos, W. Stephen Holmes, Gilbert H. Kliman, Arnold L. Oronsky and Thomas L. Rosch are Managing Directors of IMP9. Bruce A. Cleveland, Christopher B. Ehrlich, Nina Kjellson, Khaled A. Nasr, and Douglas A. Pepper are Venture Members of IMP9. Each Managing Director and Venture Member of IMP9 disclaims beneficial ownership of such shares, except to the extent of their pecuniary interest therein.